Non-complicated acute malnutrition among children 6-59 months Nutritional, Metabolic, Endocrine Malnutrition
Conditions
Interventions
Current interventions as of 01/04/2019:
The intervention tested involves the nutritional treatment of malnourished children age 6-59 months with ready-to use therapeutic foods in Kenya and South Sudan
received weekly
SFP admission - plumpy'sup RUSF 500 kcal/day
received bi-weekly
Intervention arm:
<115mm and/or oedema (+/++) - two 92g sachets RUTF/day (1000 kcal/day)
received weekly
115-<125mm – one 92g sachet RUTF/day (500 kcal/day)
received bi-weekly
Previous interventions:
The intervention tested involves the nutritional treatment of malnourished children age 6-59 months with ready-to use therapeutic foods in Kenya and
Sponsors
London School of Hygiene & Tropical Medicine
Eligibility
Sex/Gender
All
Age
6 Months to 59 Months
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 01/04/2019: 1. Children aged 6 to 59 months 2. Diagnosed with uncomplicated acute malnutrition and eligible for CMAM treatment, defined as <125mm MUAC and/or bilateral pitting oedema (+/++) in the intervention arm or <125mm MUAC and/or bilateral pitting oedema (+/++) and/or WHZ <-2 in the control arm 3. Passes appetite test (consumption of 30g of RUTF within 20 minutes) 4. No medical complications Previous participant inclusion criteria: 1. Children aged 6 to 59 months 2. Diagnosed with uncomplicated acute malnutrition and eligible for CMAM treatment, defined as <125mm MUAC and/or bilateral pitting oedema (+) in the intervention arm or <125mm MUAC and/or bilateral pitting oedema (++/+++) and/or WHZ <-2 in the control arm 3. Passes appetite test (consumption of 30g of RUTF within 20 minutes) 4. No medical complications
Exclusion criteria
Exclusion criteria: Current participant exclusion criteria as of 01/04/2019: 1. =125 mm MUAC 2. Failed appetite test (requires inpatient treatment) 3. Medical complications requiring inpatient treatment, as per international guidelines/ IMCI danger signs including but not limited to: 3.1. Oedema (+++ or higher) 3.2. Anorexia, no appetite 3.3. Intractable vomiting 3.4. Convulsions 3.5. Lethargy, not alert 3.6. Unconsciousness 3.7. Hypoglycaemia 3.8. High fever 3.9. Hypothermia 3.10. Severe dehydration 3.11. Lower respiratory tract infection 3.12. Severe anaemia 3.13. Skin lesions Previous participant exclusion criteria: 1. =125mm MUAC 2. Failed appetite test (requires inpatient treatment) 3. Medical complications requiring inpatient treatment, as per international guidelines/ IMCI danger signs including but not limited to: 3.1. Oedema (++ or higher) 3.2. Anorexia, no appetite 3.3. Intractable vomiting 3.4. Convulsions 3.5. Lethargy, not alert 3.6. Unconsciousness 3.7. Hypoglycaemia 3.8. High fever 3.9. Hypothermia 3.10. Severe dehydration 3.11. Lower respiratory tract infection 3.12. Severe anaemia 3.13. Skin lesions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery from acute malnutrition, defined as two consecutive measurements with a MUAC =125mm and no oedema, is assessed by reviewing patient records at end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 02/04/2019: 1. Coverage, defined as % of children eligible for treatment (MUAC<125mm) who receive it, is measured using a SQUEAC survey at the end of the research enrolment period 2. Program default, defined by 3 consecutive missed visits in South Sudan or 3 consecutive missed visits in Kenya, is measured by reviewing patient records monthly for the duration of the 3. Program death rate is measured by reviewing patient records monthly for the duration of the 4. Length of stay in treatment is measured by reviewing patient records to determine the duration of treatment (days) until recover), at end of treatment 5. Average daily weight gain (g/kg/day) is measured by reviewing patient records at end of treatment 6. Average daily MUAC gain (mm/day) is measured by reviewing patient records at end of treatment Previous secondary outcome measures: 1. Coverage, defined as % of children eligible for treatment (MUAC<125mm) who receive it, is measured using a SQUEAC survey at the end of the research enrolment period 2. Program default, defined by 2 consecutive missed visits in South Sudan or 3 consecutive missed visits in Kenya, is measured by reviewing patient records monthly for the duration of the 3. Program death rate is measured by reviewing patient records monthly for the duration of the 4. Length of stay in treatment is measured by reviewing patient records to determine the duration of treatment (days) until recover), at end of treatment 5. Average daily weight gain (g/kg/day) is measured by reviewing patient records at end of treatment 6. Average daily MUAC gain (mm/day) is measured by reviewing patient records at end of treatment | — |
Countries
Kenya, South Sudan
Contacts
Public ContactJeanette Bailey
Outcome results
None listed